BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 28104536)

  • 1. Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non-Small Cell Lung Cancer Patients.
    Zhu M; Geng L; Shen W; Wang Y; Liu J; Cheng Y; Wang C; Dai J; Jin G; Hu Z; Ma H; Shen H
    J Thorac Oncol; 2017 Apr; 12(4):644-656. PubMed ID: 28104536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
    Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
    J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.
    Dai J; Jin G; Dong J; Chen Y; Xu L; Hu Z; Shen H
    J Thorac Oncol; 2010 Nov; 5(11):1748-54. PubMed ID: 20881643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
    Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
    J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
    Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
    Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery.
    Lee JH; Shin KM; Lee SY; Hong MJ; Choi JE; Kang HG; Do SK; Lee WK; Lee EB; Seok Y; Jeong JY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Kim YC; Oh IJ; Na KJ; Kim MS; Lee JM; Yang HC; Jung CY; Park CK; Lee MK; Kim DK; Park JY
    Ann Surg Oncol; 2019 Oct; 26(11):3756-3764. PubMed ID: 31313037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
    Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
    Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional polymorphism on chromosome 15q25 associated with survival of early stage non-small-cell lung cancer.
    Jin G; Bae EY; Yang E; Lee EB; Lee WK; Choi JE; Jeon HS; Yoo SS; Lee SY; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
    J Thorac Oncol; 2012 May; 7(5):808-14. PubMed ID: 22722785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer.
    Seok Y; Kang HG; Lee SY; Jeong JY; Choi JE; Jung DK; Jin CC; Hong MJ; Do SK; Lee WK; Park JY; Shin KM; Yoo SS; Lee J; Cho S; Cha SI; Kim CH; Jheon S; Lee EB; Park JY
    Ann Surg Oncol; 2017 Oct; 24(11):3386-3395. PubMed ID: 28766235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variations associated with postoperative recurrence in stage I non-small cell lung cancer.
    Yoon KA; Jung MK; Lee D; Bae K; Joo JN; Lee GK; Lee HS; Lee JS
    Clin Cancer Res; 2014 Jun; 20(12):3272-9. PubMed ID: 24737549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
    Sullivan I; Salazar J; Arqueros C; Andrés M; Sebio A; Majem M; Szafranska J; Martínez E; Páez D; López-Pousa A; Baiget M; Barnadas A
    Clin Transl Oncol; 2017 Jul; 19(7):884-890. PubMed ID: 28150169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancer.
    Micke P; Edlund K; Holmberg L; Kultima HG; Mansouri L; Ekman S; Bergqvist M; Scheibenflug L; Lamberg K; Myrdal G; Berglund A; Andersson A; Lambe M; Nyberg F; Thomas A; Isaksson A; Botling J
    J Thorac Oncol; 2011 Nov; 6(11):1833-40. PubMed ID: 22011649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.
    Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P
    BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKT1 polymorphisms and survival of early stage non-small cell lung cancer.
    Kim MJ; Kang HG; Lee SY; Jeon HS; Lee WK; Park JY; Lee EB; Lee JH; Cha SI; Kim DS; Kim CH; Kam S; Jung TH; Park JY
    J Surg Oncol; 2012 Feb; 105(2):167-74. PubMed ID: 21842521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue.
    Fehringer G; Liu G; Pintilie M; Sykes J; Cheng D; Liu N; Chen Z; Seymour L; Der SD; Shepherd FA; Tsao MS; Hung RJ
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1097-104. PubMed ID: 22539604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
    Feng A; Tu Z; Yin B
    Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival.
    Guo H; Bai Y; Xu P; Hu Z; Liu L; Wang F; Jin G; Wang F; Deng Q; Tu Y; Feng M; Lu D; Shen H; Wu T
    J Clin Oncol; 2010 Apr; 28(11):1928-35. PubMed ID: 20231684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer.
    Zalewska-Ziob M; Dobija-Kubica K; Biernacki K; Adamek B; Kasperczyk J; Bruliński K; Ostrowska Z
    Acta Biochim Pol; 2017; 64(4):641-646. PubMed ID: 29141053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
    Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.